Literature DB >> 7929304

NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney.

A K Agarwal1, T Mune, C Monder, P C White.   

Abstract

11 beta-Hydroxysteroid dehydrogenase (11-HSD) catalyzes the conversion of cortisol to cortisone and corticosterone to 11-dehydrocorticosterone. This activity may be required to confer normal ligand specificity upon the mineralocorticoid receptor. Although an isozyme of 11-HSD was previously isolated from rat liver, a different isozyme is apparently expressed in mineralocorticoid target tissues. We isolated a sheep kidney cDNA clone encoding this isozyme by expression screening using Xenopus oocytes. The cDNA is 1.8 kilobase pairs in length and encodes a protein of 427 amino acid residues with a predicted M(r) of 46,700. When expressed in oocytes, this enzyme functions as an NAD(+)-dependent 11 beta-dehydrogenase with very high affinity for steroids, but it has no detectable reductase activity. It is 37% identical in amino acid sequence to an NAD(+)-dependent isozyme of 17 beta-hydroxysteroid dehydrogenase but only 20% identical to the NADP(+)-dependent liver isozyme of 11-HSD. It is expressed at high levels in the kidney and adrenal and at lower levels in the colon. The corresponding gene is present in a single copy in the sheep genome. In humans, this gene is a candidate locus for the syndrome of apparent mineralocorticoid excess, a form of hypertension postulated to result from 11-HSD deficiency in mineralocorticoid target tissues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929304

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Apparent mineralocorticoid excess syndromes.

Authors:  M Shimojo; P M Stewart
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

Review 2.  Aldosterone in the brain.

Authors:  Joel C Geerling; Arthur D Loewy
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-04

Review 3.  Crystal structures of 11β-hydroxysteroid dehydrogenase type 1 and their use in drug discovery.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  Future Med Chem       Date:  2011-03       Impact factor: 3.808

4.  Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess.

Authors:  M I New; R C Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 5.  Genetics of the mineralocorticoid system in primary hypertension.

Authors:  Paolo Ferrari
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

6.  11 beta-hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism.

Authors:  M W Voice; J R Seckl; C R Edwards; K E Chapman
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

7.  7alpha-hydroxytestosterone affects 1 beta-hydroxysteroid dehydrogenase 1 direction in rat Leydig cells.

Authors:  Guo-Xin Hu; Qing-Quan Lian; Bing-Bing Chen; Pramod V Prasad; Narender Kumar; Zhi-Qiang Zheng; Ren-Shan Ge
Journal:  Endocrinology       Date:  2009-12-16       Impact factor: 4.736

Review 8.  Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Authors:  Milla Marques Hermidorff; Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

Review 9.  Rapid mechanisms of glucocorticoid signaling in the Leydig cell.

Authors:  Guo-Xin Hu; Qing-Quan Lian; Han Lin; Syed A Latif; David J Morris; Matthew P Hardy; Ren-Shan Ge
Journal:  Steroids       Date:  2007-12-28       Impact factor: 2.668

10.  Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat.

Authors:  Elise P Gomez-Sanchez; Damian G Romero; Angela F de Rodriguez; Mary P Warden; Zygmunt Krozowski; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.